Healthcare (Brussels)
This is Queen Street Analytics' weekly digest of regulatory developments, legislative discussions and other government-related news coming out of Brussels and the EU member nations. This newsletter channel is subscribed to by many healthcare providers, doctors, physicians, clinicians, pharmacies and pharmacists, dental care providers, oral care providers, naturopaths, and old-age care providers. Once a week, we break down the most important updates in this space in under five minutes.
This Week in Healthcare — Brussels (#22, 2026)
Commission moves on biotech and cancer; Biotech Act committee opinions; Novel foods authorised; Biotech council meeting scheduled; Amended infant formula rules.
This Week in Healthcare — Brussels (#21, 2026)
Commission refers France to Court over vet sector restrictions; new rules on antimicrobials in food imports; Parliament committees adopt health workforce crisis report; Council ministers review Ebola outbreak.
This Week in Healthcare — Brussels (#20, 2026)
Biocidal product authorisations extended in Hungary, Poland, Malta; new Decision on avian influenza zones; glutaraldehyde approval extended; new plant protection labelling rules.
This Week in Healthcare — Brussels (#19, 2026)
Lithuania receives €178m NextGenerationEU payment; EIC selects EQT for €5bn Scaleup Europe Fund; Council acts on avian influenza; SANT Committee backs global health cooperation.
Lobbying on Healthcare - Brussels (May 2026 edition)
Medecins Sans Frontieres International; European Federation of Pharmaceutical Industries and Associations; PIERRE FABRE SA; MedTech Europe; MEDICINES FOR EUROPE; Ultragenyx Europe Gmbh were unusually active lobbyists last month.
This Week in Healthcare — Brussels (#18, 2026)
Critical Medicines Act political agreement; provisional anti-dumping duties on Chinese PBTC; CETA Joint Committee to include APIs in mutual recognition; new staff exchange for border controls.